RTV placebo

DRUG4 trials

Sponsors

Gilead Sciences

Conditions

Acquired Immunodeficiency SyndromeHIVHIV InfectionsHIV-1 Infection

Phase 2

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

CompletedNCT00892437

Gilead SciencesHIV-1 Infection

Start: 2009-05-31End: 2015-01-31Updated: 2016-02-15

Phase 3

Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

CompletedNCT01106586

Gilead SciencesHIV, HIV Infections

Start: 2010-04-30End: 2014-09-30Updated: 2015-11-11

Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

CompletedNCT01108510

Gilead SciencesHIV, HIV Infections

Start: 2010-04-30End: 2015-04-30Updated: 2016-05-23

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

CompletedNCT01705574

Gilead SciencesAcquired Immunodeficiency Syndrome, HIV Infections

Start: 2012-10-24End: 2018-09-06Updated: 2019-09-20

Related Papers

Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial.

2017-01-015 citations

Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study.

2016-05-2768 citations

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.

2012-06-01260 citations